Kelix Strikes A Deal To Acquire 14 Oncology Injectables
As Company Enters Morocco By Acquiring Pharmaceutical Institute
Kelix bio has announced two deals to expand its presence in Africa. The company is set to acquire 14 oncology injectable products from Germany-based Vitane. Furthermore, Kelix has acquired Pharmaceutical Institute, a pharmaceutical company established in Rabat, to enter Morocco. The pan-African company has also invested in Malta.